Notice of Intent To Grant Partially Exclusive License, 52696 [2011-21417]
Download as PDF
mstockstill on DSK4VPTVN1PROD with NOTICES
52696
Federal Register / Vol. 76, No. 163 / Tuesday, August 23, 2011 / Notices
following: the Athena I and II, Atlas V
family, the Delta family, the Falcon
family, the Minotaur family, the Pegasus
XL, and Taurus family. These launch
vehicles would accommodate the
desired range of payload masses, would
provide the needed trajectory
capabilities, and would provide highly
reliable launch services. Individual
launch vehicles would be carefully
matched to the launch requirements of
each particular NASA routine payload.
In the event that other launch vehicles
become available after final publication
of this Draft EA, they could be NEPA
compliant under this Draft EA if they
meet the following criteria: (1) NASA
has been a cooperating agency with the
Department of Defense (DoD) or FAA on
the launch vehicle for that given launch
site; (2) NASA has published NEPA
documentation for that specific launch
vehicle at that specific launch site; or (3)
NASA formally adopts another agency’s
NEPA documentation. In addition,
launch vehicles covered in this Draft EA
could be eligible for launch from
commercial spaceports or DoD
installations not covered by this
document if: (1) NASA is a cooperating
agency on the NEPA documents
developed by the DoD or FAA for that
site; (2) NASA formally adopts those
NEPA documents as its own pursuant to
CEQ regulations; or (3) NASA completes
its own NEPA documentation on a
specific launch site.
For the NASA routine payload
missions, the potentially affected
environment for normal launches
includes the areas at and in the vicinity
of the proposed launch sites, CCAFS,
Florida, VAFB, California, USAKA/RTS,
RMI, WFF, Virginia, and KLC, Alaska.
Because propellants are typically the
largest contributors to potential
environmental impacts of a NASA
Routine Payload launch, the total
propellant load for a payload is
considered in this Draft EA. If the
payload propellant load exceeds the
EPC defined in the Draft EA, then
additional NEPA analysis and
documentation would be required. For
normal launches of NASA routine
payloads under the proposed action, the
environmental impacts would be
associated principally with the exhaust
emissions from the launch vehicles.
These effects would include short-term
impacts on air quality within the
exhaust cloud and near the launch pads,
and the potential for acidic deposition
on the vegetation and surface water
bodies at and near each launch
complex, particularly if a rain storm
occurred. NASA routine payload
processing and launch activities would
not require any additional permits or
VerDate Mar<15>2010
16:33 Aug 22, 2011
Jkt 223001
mitigation measures beyond those
already existing, or in coordination, for
launches.
There are no direct or substantial
environmental impacts, including
cumulative impacts, associated with the
proposed action that have not already
been covered by NEPA documentation
for the existing launch sites, launch
vehicles, launch facilities, and payload
processing facilities.
Olga M. Dominguez,
Assistant Administrator for Strategic
Infrastructure.
[FR Doc. 2011–21419 Filed 8–22–11; 8:45 am]
BILLING CODE 7510–13–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice (11–077)]
Notice of Intent To Grant Partially
Exclusive License
National Aeronautics and
Space Administration.
ACTION: Notice of intent to grant
partially exclusive license.
AGENCY:
This notice is issued in
accordance with 35 U.S.C. 209(e) and 37
CFR 404.7(a)(1)(i). NASA hereby gives
notice of its intent to grant a partially
exclusive license in the United States to
practice the inventions described and
claimed in USPN 6,133,036,
Preservation of Liquid Biological
Samples, NASA Case No. MSC- 22616–
2 and USPN 6,716,392, Preservation of
Liquid Biological Samples, NASA Case
No. MSC- 22616–3 to Quest Diagnostics
Incorporated having its principal place
of business in Madison, New Jersey. The
patent rights in these inventions have
been assigned to the United States of
America as represented by the
Administrator of the National
Aeronautics and Space Administration.
The prospective partially exclusive
license will comply with the terms and
conditions of 35 U.S.C. 209 and 37 CFR
404.7.
DATES: The prospective partially
exclusive license may be granted unless
within fifteen (15) days from the date of
this published notice, NASA receives
written objections including evidence
and argument that establish that the
grant of the license would not be
consistent with the requirements of
35 U.S.C. 209 and 37 CFR 404.7.
Competing applications completed and
received by NASA within fifteen (15)
days of the date of this published notice
will also be treated as objections to the
grant of the contemplated partially
exclusive license.
Objections submitted in response to
this notice will not be made available to
the public for inspection and, to the
extent permitted by law, will not be
released under the Freedom of
Information Act, 5 U.S.C. 552.
ADDRESSES: Objections relating to the
prospective license may be submitted to
Patent Counsel, Office of Chief Counsel,
NASA Johnson Space Center, 2101
NASA Parkway, Houston, Texas 77058,
Mail Code AL; Phone (281) 483–3021;
Fax (281) 483–6936.
FOR FURTHER INFORMATION CONTACT: Kurt
G. Hammerle, Intellectual Property
Attorney, Office of Chief Counsel,
NASA Johnson Space Center, 2101
NASA Parkway, Houston, Texas 77058,
Mail Code AL; Phone (281) 483–1001;
Fax (281) 483–6936. Information about
other NASA inventions available for
licensing can be found online at
https://technology.nasa.gov/.
Dated: August 17, 2011.
Richard W. Sherman,
Deputy General Counsel.
[FR Doc. 2011–21417 Filed 8–22–11; 8:45 am]
BILLING CODE P
SUMMARY:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
OFFICE OF NATIONAL DRUG
CONTROL POLICY
Paperwork Reduction Act; Proposed
Collection; Comment Request
Office of National Drug Control
Policy.
ACTION: 30-Day notice and request for
comments. New Information Collection
Request: Drug Free Communities
Support Program National Evaluation.
AGENCY:
The Office of National Drug
Control Policy (ONDCP) intends to
submit the following information
collection request to the Office of
Management and Budget for review and
approval under the Paperwork
Reduction Act.
DATES: ONDCP encourages and will
accept public comments until
September 22, 2011.
ADDRESSES: Address all comments in
writing within 30 days to Mr. Patrick
Fuchs. Facsimile and e-mail are the
most reliable means of communication.
Mr. Fuchs facsimile number is (202)
395–5167, and his e-mail address is
pfuchs@omb.eop.gov. Mailing address is
725 17th Street, NW., Washington DC
20503. For further information contact
Mr. Fuchs at (202) 395–3897.
Abstract: ONDCP directs the Drug
Free Communities (DFC) Program in
partnership with the Substance Abuse
and Mental Health Services
Administration’s Center for Substance
SUMMARY:
E:\FR\FM\23AUN1.SGM
23AUN1
Agencies
[Federal Register Volume 76, Number 163 (Tuesday, August 23, 2011)]
[Notices]
[Page 52696]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-21417]
-----------------------------------------------------------------------
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
[Notice (11-077)]
Notice of Intent To Grant Partially Exclusive License
AGENCY: National Aeronautics and Space Administration.
ACTION: Notice of intent to grant partially exclusive license.
-----------------------------------------------------------------------
SUMMARY: This notice is issued in accordance with 35 U.S.C. 209(e) and
37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant
a partially exclusive license in the United States to practice the
inventions described and claimed in USPN 6,133,036, Preservation of
Liquid Biological Samples, NASA Case No. MSC- 22616-2 and USPN
6,716,392, Preservation of Liquid Biological Samples, NASA Case No.
MSC- 22616-3 to Quest Diagnostics Incorporated having its principal
place of business in Madison, New Jersey. The patent rights in these
inventions have been assigned to the United States of America as
represented by the Administrator of the National Aeronautics and Space
Administration. The prospective partially exclusive license will comply
with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
DATES: The prospective partially exclusive license may be granted
unless within fifteen (15) days from the date of this published notice,
NASA receives written objections including evidence and argument that
establish that the grant of the license would not be consistent with
the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Competing
applications completed and received by NASA within fifteen (15) days of
the date of this published notice will also be treated as objections to
the grant of the contemplated partially exclusive license.
Objections submitted in response to this notice will not be made
available to the public for inspection and, to the extent permitted by
law, will not be released under the Freedom of Information Act, 5
U.S.C. 552.
ADDRESSES: Objections relating to the prospective license may be
submitted to Patent Counsel, Office of Chief Counsel, NASA Johnson
Space Center, 2101 NASA Parkway, Houston, Texas 77058, Mail Code AL;
Phone (281) 483-3021; Fax (281) 483-6936.
FOR FURTHER INFORMATION CONTACT: Kurt G. Hammerle, Intellectual
Property Attorney, Office of Chief Counsel, NASA Johnson Space Center,
2101 NASA Parkway, Houston, Texas 77058, Mail Code AL; Phone (281) 483-
1001; Fax (281) 483-6936. Information about other NASA inventions
available for licensing can be found online at https://technology.nasa.gov/.
Dated: August 17, 2011.
Richard W. Sherman,
Deputy General Counsel.
[FR Doc. 2011-21417 Filed 8-22-11; 8:45 am]
BILLING CODE P